During the past decade, Carolina Arthritis Associates conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carolina Arthritis Associates" #1 sponsor was "Bristol-Myers Squibb" with 4 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "MediQuest Therapeutics" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "R-Pharm International, LLC" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carolina Arthritis Associates" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator, "Mene Research" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Carolina Arthritis Associates" are "Rheumatoid Arthritis" (8 trials), "Axial Spondyloarthritis" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Osteoarthritis" (1 trials). Many other conditions were trialed in "Carolina Arthritis Associates" in a lesser frequency.

Most popular intervention types in "Carolina Arthritis Associates" are "Drug" (16 trials), "Biological" (1 trials), "Combination Product" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Abatacept" (3 trials), "Methotrexate" (3 trials), "Ixekizumab" (2 trials) and "0.9% nitroglycerin in TAM cream" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carolina Arthritis Associates" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Carolina Arthritis Associates". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Carolina Arthritis Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Carolina Arthritis Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".